Apoptosis: MBBS, FCPS, M.Phil. Histopathology Department of Pathology CMHLMC

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 42

Apoptosis

Dr Uzma Rihan
MBBS, FCPS, M.Phil. Histopathology
Department of Pathology
CMHLMC
• Learning Objectives:

• At the end of the lecture students will be able to:

 Enlist causes of Apoptosis

 Describe mechanisms of Apoptosis

 Enlist Differences between Necrosis and Apoptosis


Apoptosis

• Apoptosis is a pathway of cell death in living tissues


that is induced by a tightly regulated suicide program in
which cells destined to die activate intrinsic enzymes
that degrade the cells' own nuclear DNA and nuclear
and cytoplasmic proteins.

• Programmed cell Death


Apoptosis

 Physiological
 Pathological

 Physiological Apoptosis:
• Death by apoptosis is a normal phenomena & it serve to to
eliminate unwanted, aged or potentially harmful cells that are no
longer needed, and to maintain a steady number of various cell
populations in tissues.
Apoptosis in Physiologic Situations

 Destruction of cells during embryogenesis;


 Implantation
 Organogenesis
 Developmental involution.

 Involution of hormone-dependent tissues upon hormone


withdrawal:
 Endometrial cell breakdown during the menstrual cycle.
 Ovarian follicular atresia in menopause.
 Regression of the lactating breast after weaning
 Testicular atrophy due to androgens deficiency.
Apoptosis in Physiologic Situations

 Destruction of cells during


embryogenesis:

 Implantation
 Organogenesis
 Developmental involution.
Apoptosis in Physiologic Situations

 Involution of hormone-dependent
tissues upon hormone
withdrawal:

 Endometrial cell breakdown during


the menstrual cycle.

 Ovarian follicular atresia in


menopause.

 Regression of the lactating breast


after weaning.

 Testicular atrophy due to


androgens deficiency.
Apoptosis in Physiologic Situations

 Cell loss in proliferating cell


populations:

 Immature lymphocytes in the bone


marrow & thymus.

 B lymphocytes in germinal centers.

 Epithelial cells in intestinal crypts,


so as to maintain a constant
number (homeostasis).
Apoptosis in Physiologic Situations

 Elimination of potentially harmful self-reactive lymphocytes.

 Death of host cells that have served their useful purpose.

 Neutrophils in an acute inflammatory response.


 Lymphocytes at the end of an immune response.
Apoptosis in Pathologic Conditions
Apoptosis eliminates cells that are injured beyond repair without
eliciting a host reaction, thus limiting surrounding tissue damage.

DNA damage:
 Radiation
 Cytotoxic anticancer drugs
 Hypoxia

• Repair mechanisms cannot cope with the injury--- triggers intrinsic


mechanisms ---- Apoptosis.

• If insult is mild by these injurious stimuli --- Apoptosis

• But larger doses of the same stimuli --Necrotic cell death


Apoptosis in Pathologic Conditions

 Accumulation of Misfolded Proteins:


• Improperly folded proteins may accumulate in the cells because of:
 Mutations in the genes encoding these proteins.
 Extrinsic factors e.g. ROS.

• Excessive accumulation misfolded proteins in the ER ----ER


stress--- Apoptotic cell death.

• Examples: degenerative diseases of the CNS and other organs.


Apoptosis in Pathologic Conditions

 Cell death in certain infections:


 Adenovirus, HBV, HCV and HIV infected cells die by Apoptosis.

 Cell death in tumors and in transplant rejection by Apoptosis.


  
 Pathologic atrophy in parenchymal organs after duct obstruction
e.g. pancreas & parotid gland by Apoptosis.
Morphological Changes in Apoptosis

 Cell shrinkage: condensation of


cytoplasm + tightly packed organelles.

 Chromatin condensation &


fragmentation of nucleus.

 Formation of cell membrane blebs.

 Fragmentation of apoptotic cells into


membrane-bound apoptotic bodies

 Phagocytosis of apoptotic bodies,


usually by macrophages.
Morphological Changes in Apoptosis

• Apoptotic cell appears as a


round or oval mass of
intensely eosinophilic
cytoplasm with fragments of
dense nuclear chromatin
MECHANISMS OF APOPTOSIS

 Activation of Caspases.
• Activation of cysteine proteases named caspases.

• More than 10 members of Caspase family.


• Functionally divided into two groups:

 Initiators------------ caspase-8 and caspase-9.


 Executioners----caspase-3 and caspase-6.

 Caspases exist as inactive pro-enzymes, or zymogens.


 Enzymatic cleavage ----------- Active.
 Active caspases----------------- Apoptosis.
MECHANISMS OF APOPTOSIS

Two phases of Apoptosis:


 Initiation phase
 Execution phase

 Pathways for initiation of apoptosis :


 Intrinsic, or mitochondrial, pathway.
 Extrinsic, or death receptor–initiated, pathway .
Initiation Phase
Intrinsic (Mitochondrial) Pathway of Apoptosis

• Increased mitochondrial membrane permeability and release of


pro-apoptotic molecules (death inducers) from mitochondrial
intermembrane space into the cytoplasm.

• The release of these mitochondrial proteins is controlled by BCL-2 (B-


cell lymphoma 2) family of proteins encoded by BCL-2 gene

• BCL-2 Family of protein,----20 members


 Anti-apoptotic proteins (BCL-2, BCL-XL,MCL-1)
 Proapoptotic proteins (BAX & BAK)
 Sensors of damage or sensors of stress (BH3-only proteins,
BAD,BID, PUMA).
 Intrinsic (Mitochondrial)
Pathway of Apoptosis
 Anti-apoptotic proteins:
 BCL2, BCL-XL and MCL-1.

• BCL-2 & BCL-XL reside in the


outer mitochondrial membranes.

• Prevent leakage of mitochondrial


proteins cytochrome c .
• Proapoptotic proteins: BAX
and BAK.

• Release of BAX, BAK when:


 Lack of survival signals
 Damaged DNA (radiations)
 Misfolded proteins induce ER
stress.

 BAX and BAK. ------ insert into


the mitochondrial membrane ----
 leakage of Cytochrome –c into
the cytoplasm.
Initiation Phase
Intrinsic (Mitochondrial) Pathway of Apoptosis

 Into the cytosol, cytochrome c binds to a protein called APAF-1


(apoptosis-activating factor-1 --- activation of caspase-9.

 Caspase-9 cleaves adjacent caspase-9 molecules-----> Auto-


amplification process.

 Other mitochondrial proteins (Apoptosis inducing factors AIF) in the


cytoplasm bind to and neutralize inhibitors of apoptosis ( IAPs).
Initiation Phase
Intrinsic (Mitochondrial) Pathway of Apoptosis
 Sensors of cellular damage or stress : BIM, BID, and BAD, Puma
& Noxa OR “BH3-only proteins.”
 “BH3-only proteins.” -- activate proapoptotic proteins BAX and
BAK.

 BH3-only proteins bind and block the function of BCL-2 and BCL-X
(Anti-apoptotic proteins) & decrease their synthesis.

 Net result :
 BAX-BAK activation (pro-apoptotic proteins) + loss of anti-
apoptotic BCL-2 & BCL-X ------ release of mitochondrial proteins
( cytochrom-c) in cytoplasm ------- Caspases activation
Initiation Phase
The Extrinsic Death Receptor–Pathway of Apoptosis
• Death receptors on plasma
membrane

• Cytoplasmic domain is called


the death domain.

• Best-known death receptors:

 Type 1 TNF receptor (TNFR1)


 Fas (CD95).
 Ligand for Fas is Fas ligand
(FasL).
The Extrinsic Death Receptor–Pathway of
Apoptosis
FasL is expressed on:

 T cells that recognize self


antigens.
 Cytotoxic T lymphocytes.

• When FasL binds to Fas, three


or more molecules of Fas are
brought together.

• Their cytoplasmic death


domains form a binding site
for an adapter protein FADD
(Fas-associated death
domain)
The Extrinsic Death Receptor–Pathway of Apoptosis
FADD + death receptors active
pro caspase-8.

Active Capases-8 & 10--->


activation of other pro-
caspases----> execution phase
of apoptosis.

Inhibition of Extrinsic pathway


of apoptosis:
 Protein FLIP, which bind to pro
caspases 8 and inhibit there
cleavage.
 Some viruses and normal cells
produce FLIP.
Execution Phase of Apoptosis

• Two initiating pathways:


• Mitochondrial pathway -------- Activation of caspase-9.
 Death receptor pathway ------- Activation of caspase-8 and -10.

• After activation of initiator caspases ----- activation of


executioner caspases, caspase-3 and -6.

 Activation of DNAase ----- cleavage of DNA.

 Caspases ---lysis of nuclear matrix-------fragmentation of nuclei.


Removal of Dead Cells
Apoptotic bodies : “tasty” targets for phagocytes
Changes in the membranes of Apoptotic bodies & release of “Eat me or find me’ signals ----- Migration of phagocytes.
Removal of Dead Cells

 In healthy cells Phosphatidylserine is present on the inner leaflet of


the plasma membrane.

 In apoptotic cells this phospholipid “flips” out --- expressed on


the outer layer of the membrane------- recognized macrophages
Removal of Dead Cells

 Some apoptotic bodies express thrombospondin, an adhesive


glycoprotein --- recognized by phagocytes.

 Macrophages produce proteins --- bind to apoptotic cells (but not


to live cells) --- target the dead cells for engulfment.

 Natural antibodies and C1q- coat the apoptotic bodies & then
recognized by phagocytes.
Disorders Associated with Dysregulated
Apoptosis
• Disorders associated with defective apoptosis and increased cell
survival.

 Low rate of apoptosis- survival of cells with DNA damage ----->


Cancer

 Defective apoptosis due to Mutation of p53 is the most common


genetic abnormality found in human cancers.

 Defective apoptosis --- failure to eliminate self-reactive lymphocytes.


 -----Autoimmune disorders.
Disorders Associated with Increased Apoptosis
and excessive cell death

 Neurodegenerative diseases;
loss of specific sets of neurons, in
which apoptosis is caused by
mutations and misfolded proteins.

 Ischemic injury : myocardial


infarction & Stroke.

 Death of virus-infected cells

You might also like